DHRM [Dehaier Medical Systems] 20-F: (Original Filing)

[TABLE OF CONTENTS Item 1. Identity of Directors, Senior Management and Advisers 1 Item 2. Offer Statistics and Expected Timetable 1 Item 3. Key Information 1 Item 4. Information on the Company 16 Item 4A. Unresolved Staff Comments 33 Item 5. Operating and Financial Review and Prospects 33 Item 6. Directors, Senior Management and Employees 45 Item 7. Major Shareholder] [I, Ping Chen, certify that: (1) I have reviewed this Form 20-F of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [Certification of Principal Financial Officer Huili (Alisa) Li, certify that: I, (1) I have reviewed this Form 20-F of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Huili (Alisa) Li, certify that: (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Huili (Alisa) Li Chief Financial Officer (Principal Financial Officer)] [Dehaier Medical Systems Reports Full Year 2014 Financial Results Company to Conduct Conference Call at 8:30 a.m. EDT on April 30, 2015 BEIJING, April 30, 2015 -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), which develops, markets and sells medical devices and wearable sleep respiratory products in China, today reported its financial results for the fiscal year]

DHRM [Dehaier Medical Systems] 20-F: TABLE OF CONTENTS Item 1. Identity of Directors,

[TABLE OF CONTENTS Item 1. Identity of Directors, Senior Management and Advisers 1 Item 2. Offer Statistics and Expected Timetable 1 Item 3. Key Information 1 Item 4. Information on the Company 16 Item 4A. Unresolved Staff Comments 33 Item 5. Operating and Financial Review and Prospects 33 Item 6. Directors, Senior Management and Employees 45 Item 7. Major Shareholder] [I, Ping Chen, certify that: (1) I have reviewed this Form 20-F of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [Certification of Principal Financial Officer Huili (Alisa) Li, certify that: I, (1) I have reviewed this Form 20-F of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Huili (Alisa) Li, certify that: (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Huili (Alisa) Li Chief Financial Officer (Principal Financial Officer)] [Dehaier Medical Systems Reports Full Year 2014 Financial Results Company to Conduct Conference Call at 8:30 a.m. EDT on April 30, 2015 BEIJING, April 30, 2015 -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), which develops, markets and sells medical devices and wearable sleep respiratory products in China, today reported its financial results for the fiscal year]

MR [Mindray Medical International] IRANNOTICE: (Original Filing)

[Iran Notice Re: Notice of Disclosure Filed in Annual Report on Form 20-F Under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act 100 F Street, N.E. Dear Sirs: Sincerely yours, Alex Lung Chief Financial Officer IRANNOTICE 1 v406536_iran.htm IRANNOTICE]

MR [Mindray Medical International] IRANNOTICE: Iran Notice Re: Notice of Disclosure Filed in

[Iran Notice Re: Notice of Disclosure Filed in Annual Report on Form 20-F Under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act 100 F Street, N.E. Dear Sirs: Sincerely yours, Alex Lung Chief Financial Officer IRANNOTICE 1 v406536_iran.htm IRANNOTICE]

MR [Mindray Medical International] 20-F: (Original Filing)

[Table of Contents INTRODUCTION 3 PART I. 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 ITEM 4. INFORMATION ON THE COMPANY 32 ITEM 4A. UNRESOLVED STAFF COMMENTS 54 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 54 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [Country of Name of Company Incorporation and Operation Shareholding Principal Activities Shenzhen Mindray Bio-Medical Electronics Co., Ltd. PRC MR Investments (HK) Limited: 88.918828% MR Holdings (HK) Limited: 11.081086% Non-controlling interest:0.000087%* Manufacturing and sales of medical equipment, research and development of related products and investment holding Shenzhen Mindray Investment & Development Co., Ltd. PRC Shenzhen Mindray Bio-Medical Electronics Co., Ltd.:99% Nanjing] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Cheng Minghe, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Li Xiting Executive Chairman of the Board of Directors, President and Co-Chief Executive Officer Cheng Minghe Co-Chief Executive Officer and Chief Strategic Officer Alex Lung Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 16, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

MR [Mindray Medical International] 20-F: Table of Contents INTRODUCTION 3 PART I. 4

[Table of Contents INTRODUCTION 3 PART I. 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 ITEM 4. INFORMATION ON THE COMPANY 32 ITEM 4A. UNRESOLVED STAFF COMMENTS 54 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 54 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [Country of Name of Company Incorporation and Operation Shareholding Principal Activities Shenzhen Mindray Bio-Medical Electronics Co., Ltd. PRC MR Investments (HK) Limited: 88.918828% MR Holdings (HK) Limited: 11.081086% Non-controlling interest:0.000087%* Manufacturing and sales of medical equipment, research and development of related products and investment holding Shenzhen Mindray Investment & Development Co., Ltd. PRC Shenzhen Mindray Bio-Medical Electronics Co., Ltd.:99% Nanjing] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Cheng Minghe, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Li Xiting Executive Chairman of the Board of Directors, President and Co-Chief Executive Officer Cheng Minghe Co-Chief Executive Officer and Chief Strategic Officer Alex Lung Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 16, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2014 Fourth Quarter and Full Year Results SHENZHEN, China, March 9, 2015 -- Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2014. Highlights for Fourth Quarter and Full Year 2014 - Full] []

MR [Mindray Medical International] 6-K: Mindray Announces 2014 Fourth Quarter and Full Year

[Mindray Announces 2014 Fourth Quarter and Full Year Results SHENZHEN, China, March 9, 2015 -- Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2014. Highlights for Fourth Quarter and Full Year 2014 - Full] []

MR [Mindray Medical International] SC 13G: 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS.

[1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). EARNEST Partners, LLC ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Georgia ------------------------------------------------------------------------------- 5 SOLE VOTING POWER 3,024,194 NUMBER OF -----------------------------------------------------------------]

MR [Mindray Medical International] SC 13G: (Original Filing)

[1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). EARNEST Partners, LLC ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Georgia ------------------------------------------------------------------------------- 5 SOLE VOTING POWER 3,024,194 NUMBER OF -----------------------------------------------------------------]

Skip to toolbar